These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12023167)

  • 1. Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?
    McIntosh ED; Booy R
    Arch Dis Child; 2002 Jun; 86(6):403-6. PubMed ID: 12023167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?
    McIntosh ED
    Arch Dis Child; 2003 Oct; 88(10):859-61. PubMed ID: 14500302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
    Choi YH; Andrews N; Miller E
    PLoS Med; 2019 Jul; 16(7):e1002845. PubMed ID: 31269018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006-2014.
    Oligbu G; Collins S; Sheppard CL; Fry NK; Slack M; Borrow R; Ladhani SN
    Clin Infect Dis; 2017 Jul; 65(2):308-314. PubMed ID: 28605414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.
    Myint TT; Madhava H; Balmer P; Christopoulou D; Attal S; Menegas D; Sprenger R; Bonnet E
    Adv Ther; 2013 Feb; 30(2):127-51. PubMed ID: 23397399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and wales.
    Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
    Clin Infect Dis; 2013 Mar; 56(5):633-40. PubMed ID: 23175560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
    Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
    Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016.
    Oligbu G; Collins S; Djennad A; Sheppard CL; Fry NK; Andrews NJ; Borrow R; Ramsay ME; Ladhani SN
    Emerg Infect Dis; 2019 Sep; 25(9):1708-1718. PubMed ID: 31441745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
    Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control.
    Thorrington D; Andrews N; Stowe J; Miller E; van Hoek AJ
    BMC Med; 2018 Feb; 16(1):13. PubMed ID: 29415741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pneumococcal disease in England and Wales: vaccination implications.
    Sleeman K; Knox K; George R; Miller E; Waight P; Griffiths D; Efstratiou A; Broughton K; Mayon-White RT; Moxon ER; Crook DW; ;
    J Infect Dis; 2001 Jan; 183(2):239-246. PubMed ID: 11120930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.
    Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
    Clin Infect Dis; 2014 Feb; 58(4):517-25. PubMed ID: 24300040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.
    Ladhani SN; Slack MP; Andrews NJ; Waight PA; Borrow R; Miller E
    Emerg Infect Dis; 2013 Jan; 19(1):61-8. PubMed ID: 23259937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.
    Miller E; Waight P; Efstratiou A; Brisson M; Johnson A; George R
    Acta Paediatr Suppl; 2000 Dec; 89(435):11-6. PubMed ID: 11194790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.